On the other hand, the Excision Repair Cross-Complimenting Group 1 (ERCC1) plays a pivotal role in tumour cell DNA repair mechanisms, impacting the efficacy of DNA-damaging chemotherapy agents such as cisplatin. The gene discussed is ERCC1; the disease is neoplasm.